STUDY BIOCHEMICAL PARAMETER LDH IN OVARIAN TUMORS BEFORE AND AFTER CHEMOTHERAPY

Dr.g.veena Murty Md, Dr.prem Kumar, Dr. G. Rajeswari

Abstract


Serum LDH elevations occur in a variety of clinical conditions including of MI, hemolysis and disorders of the liver,
kidneys, lung and muscle. A systematic review of Literature concluded that serum LDH is relevant in the diagnosis of MI,
hemolytic anemia, ovarian dysgerminoma and testicular germ cell tumor. Although not that relavent for epithelial
ovarian cancer, LDH is considered important in the follow up of dysgerminoma for assessing response to therapy and
prognostification of disease. The current study designied with an aim To explore the changes in LDH levels of malignant
and benign ovarian tumours pre therapy and post therapy.To explore the differences in the LDH levels between healthy
individuals and patients with ovarian tumours.To study the Correlation between CA125 and LDH. To study the
Correlation between CA125 LDH.
A study was conducted on 40 patients suffering from ovarian tumors (Benign and Malignant) who had reported to
Rangaraya Medical College hospital, Kakinada. The mean duration of symptoms was 12.6 ± 20.89 weeks (range 0.4- 104
weeks) and the median was 6.5 weeks in our cohort of patients. The mean duration of symptoms for benign (n=11)
tumors was 23.1 ± 33.1 weeks whereas for malignant (n=29) tumors the duration of symptoms was 8.62 ± 12.50 weeks. all
patients with ovarian tumours (both malignant & benign) had a pretreatment mean ± SD value of CA125 was 767 ±1069
U/ml which reduced to a mean± SD value of 46.28 ± 41.28 U/ml post treatment (p< 0.0004).
A significant change was found in the levels of LDH (Pretreatment value of 479±320.6 U/L and post treatment levels of
182.8±107U/L) (P<0.0001). When compared to healthy controls (mean CA-125:15.48 (range:5.7-22) & mean LDH:182.8
(range:140-300) [table-7], ovarian tumour patients had a higher CA-125 & LDH levels(mean CA-125: 767 & mean
LDH:479.36). We also tried to see the correlation between CA-125 and LDH both in benign and malignant ovarian
tumours. A positive correlation was found between CA125 levels and LDH in malignant ovarian tumours. In benign
tumours, a positive correlation was found between CA125 and LDH. a negative correlation was observed between CA-
125 and cholesterol levels.


Full Text:

PDF

References


David Schneider, MD, et al. Peritoneal Fluid Lactate Dehydrogenase in ovarian cancer. Gynecologic Oncology.1997; 66, 399 – 404.

Kucukgoz Gulec U, Paydas S, Guzel AB, Buyukkurt S, Seydaoglu G, Vardar MA.Comparative analysis of CA-125, Ferritin, Beta 2 Micro Globulin, LDH levels in serum and peritoneal fluids in patients with ovarian neoplasm. Kucukgoz U et al. Medical Oncology. 2012: 29: 2937-2943.

Kikuchi Y, Hisano A, Kuki E, Hirata J, Nagata I. Total lactate dehydrogenase and its isozymes in serum from patients with primary carcinoma of the ovary.. Gynecol Obstet Invest. 1991; 31(3):161-5.

Umran Kucukgoz Gulec, et al, Med Oncol. 2012 Dec;29 (4):2937-43.

Karen Eagle and Jonathan A. Ledermann, Diagnostic and prognostic value of serum and peritoneal fluid lactate dehydrogenase in epithelial ovarian cancer The Oncologist October 1997 vol. 2 no. 5 324-329, Eur J Gynaecol Oncol. 2001;22(3):228-32.

Yüce K, Baykal C, Genç C, Al A, Ayhan A . Diagnostic and prognostic value of serum and peritoneal fluid lactate dehydrogenase in epithelial ovarian cancer.Eur J Gynaecol Oncol. 2001;22 (3):228-32.

Boran N, Kayikçioğlu F, Yalvaç S, Tulunay G, Ekinci U, Köse MF). Significance of serum and peritoneal fluid lactate dehydrogenase levels in ovarian cancer.Gynecol Obstet Invest. 2000;49(4):272-4.


Refbacks

  • There are currently no refbacks.